Article
Chimeric Antigen Receptor Regulatory T Cell in Transplantation: The Future of Cell Therapy?
8 Apr 2022
Abstract excerpt
Adoptive immunotherapy with regulatory T cells (Tregs) has the potential for treatment of autoimmune disease and as immunosuppression after solid-organ transplantation. Tregs are CD4+ T lymphocytes that express the Forkhead box p3 transcription factor. These cells dampen immune responses through a number of different potential mechanisms. Until now, the only populations of Tregs administered by adoptive transfer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
